Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
Clinical trial NCT01090011 · COMPLETED
Trial details
- NCT number
- NCT01090011
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2013-01-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.